JP2547714B2
(ja)
*
|
1981-10-23 |
1996-10-23 |
モルキユラ− バイオシステムズ インコ−ポレテツド |
オリゴヌクレオチド治療剤及びその製法
|
NZ209840A
(en)
*
|
1983-10-17 |
1988-11-29 |
Kaji Akira |
A method of inhibiting viral propagation by hybridising dna with the viral rna thus blocking its action
|
US5208149A
(en)
*
|
1983-10-20 |
1993-05-04 |
The Research Foundation Of State University Of New York |
Nucleic acid constructs containing stable stem and loop structures
|
US5190931A
(en)
*
|
1983-10-20 |
1993-03-02 |
The Research Foundation Of State University Of New York |
Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
|
US5272065A
(en)
*
|
1983-10-20 |
1993-12-21 |
Research Foundation Of State University Of New York |
Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
|
US4751181A
(en)
*
|
1984-12-31 |
1988-06-14 |
Duke University |
Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
|
ATE201444T1
(de)
*
|
1985-03-21 |
2001-06-15 |
Johnston Stephen Ph D |
Vom parasit abgeleiteter widerstand
|
US5580716A
(en)
*
|
1985-03-21 |
1996-12-03 |
Stephen A. Johnston |
Parasite-derived resistance
|
US4959463A
(en)
*
|
1985-10-15 |
1990-09-25 |
Genentech, Inc. |
Intermediates
|
EP0252940A4
(en)
*
|
1985-12-05 |
1989-07-27 |
Hutchinson Fred Cancer Res |
ANTI-DETECTION RNA FOR THE TREATMENT OF RETROVIRAL DISEASES.
|
US5453566A
(en)
*
|
1986-03-28 |
1995-09-26 |
Calgene, Inc. |
Antisense regulation of gene expression in plant/cells
|
US4806463A
(en)
*
|
1986-05-23 |
1989-02-21 |
Worcester Foundation For Experimental Biology |
Inhibition of HTLV-III by exogenous oligonucleotides
|
US5637573A
(en)
*
|
1986-05-23 |
1997-06-10 |
Agrawal; Sudhir |
Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions
|
US5194428A
(en)
*
|
1986-05-23 |
1993-03-16 |
Worcester Foundation For Experimental Biology |
Inhibition of influenza virus replication by oligonucleotide phosphorothioates
|
AU613989B2
(en)
*
|
1987-11-24 |
1991-08-15 |
Gen-Probe Incorporated |
Means and method for enhancing nucleic acid hybridization
|
EP0348458B1
(en)
*
|
1987-11-30 |
1997-04-09 |
University Of Iowa Research Foundation |
Dna molecules stabilized by modifications of the 3'-terminal phosphodiester linkage and their use as nucleic acid probes and as therapeutic agents to block the expression of specifically targeted genes
|
JPH03505672A
(ja)
*
|
1988-07-05 |
1991-12-12 |
ベイラー カレッジ オブ メディシン |
高分子合成オペロンの相補アンチセンス オリゴヌクレオチド抗菌、バクテリヤ感染の処置方法
|
US5004810A
(en)
*
|
1988-09-30 |
1991-04-02 |
Schering Corporation |
Antiviral oligomers
|
FR2687679B1
(fr)
*
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
FR2686882B1
(fr)
*
|
1992-02-05 |
1994-05-06 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
US5633360A
(en)
*
|
1992-04-14 |
1997-05-27 |
Gilead Sciences, Inc. |
Oligonucleotide analogs capable of passive cell membrane permeation
|
US6824976B1
(en)
|
1993-04-02 |
2004-11-30 |
Rigel Pharmaceuticals, Inc. |
Method for selective inactivation of viral replication
|
EP0693126B9
(en)
*
|
1993-04-02 |
2007-09-12 |
Rigel Pharmaceuticals, Inc. |
Method for selective inactivation of viral replication
|
US5728518A
(en)
*
|
1994-01-12 |
1998-03-17 |
The Immune Response Corporation |
Antiviral poly-and oligonucleotides
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6429199B1
(en)
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
EP0855184A1
(en)
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
EP1039935A4
(en)
|
1997-02-28 |
2005-04-27 |
Univ Iowa Res Found |
USE OF NUCLEIC ACIDS CONTAINING NON-METHYLATED CpG DINUCLEOTIDES IN THE TREATMENT OF LIPOPOLYSACCHARIDE-ASSOCIATED ILLNESSES
|
EP1005368B1
(en)
|
1997-03-10 |
2009-09-02 |
Ottawa Hospital Research Institute |
Use of nucleic acids containing unmethylated CpG dinucleotide in combination with alum as adjuvants
|
US7262173B2
(en)
*
|
1997-03-21 |
2007-08-28 |
Georgetown University |
Chemosensitizing with liposomes containing oligonucleotides
|
US6126965A
(en)
*
|
1997-03-21 |
2000-10-03 |
Georgetown University School Of Medicine |
Liposomes containing oligonucleotides
|
CA2326823A1
(en)
*
|
1998-04-20 |
1999-10-28 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
EP1077722B1
(en)
|
1998-05-22 |
2006-08-09 |
Ottawa Health Research Institute |
Methods and products for inducing mucosal immunity
|
US6887464B1
(en)
|
1999-02-02 |
2005-05-03 |
Biocache Pharmaceuticals, Inc. |
Advanced antigen presentation platform
|
US7776343B1
(en)
|
1999-02-17 |
2010-08-17 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
US6977245B2
(en)
|
1999-04-12 |
2005-12-20 |
The United States Of America As Represented By The Department Of Health And Human Services |
Oligodeoxynucleotide and its use to induce an immune response
|
US6949520B1
(en)
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
DE60131430T2
(de)
|
2000-01-14 |
2008-10-16 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
|
ES2307568T3
(es)
|
2000-12-08 |
2008-12-01 |
Coley Pharmaceutical Gmbh |
Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
|
US7666674B2
(en)
|
2001-07-27 |
2010-02-23 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
|
AU2002361468A1
(en)
|
2001-08-14 |
2003-03-18 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human S |
Method for rapid generation of mature dendritic cells
|
EP1446162B1
(en)
|
2001-08-17 |
2008-10-15 |
Coley Pharmaceutical GmbH |
Combination motif immune stimulatory oligonucleotides with improved activity
|
US7514414B2
(en)
|
2001-09-24 |
2009-04-07 |
The United States Of America As Represented By The Department Of Health And Human Services |
Suppressors of CpG oligonucleotides and methods of use
|
WO2004012669A2
(en)
|
2002-08-01 |
2004-02-12 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating inflammatory arthropathies with suppressors of cpg oligonucleotides
|
EP1455593B1
(en)
|
2001-10-06 |
2013-07-24 |
Merial Limited |
Methods and compositions for promoting growth and innate immunity in young animals
|
US8466116B2
(en)
|
2001-12-20 |
2013-06-18 |
The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Use of CpG oligodeoxynucleotides to induce epithelial cell growth
|
AU2002366710A1
(en)
|
2001-12-20 |
2003-07-09 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of |
USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
|
IL164354A0
(en)
|
2002-04-04 |
2005-12-18 |
Coley Pharm Gmbh |
Immunostimulatory g,u-containing oligoribonucleotides
|
WO2003102011A1
(en)
*
|
2002-05-29 |
2003-12-11 |
Neopharm, Inc. |
Method for determining oligonucleotide concentration
|
US7704965B2
(en)
*
|
2002-06-26 |
2010-04-27 |
The Penn State Research Foundation |
Methods and materials for treating human papillomavirus infections
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
US8263091B2
(en)
|
2002-09-18 |
2012-09-11 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
|
WO2004033638A2
(en)
*
|
2002-10-07 |
2004-04-22 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
US8043622B2
(en)
|
2002-10-08 |
2011-10-25 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating inflammatory lung disease with suppressors of CpG oligonucleotides
|
AU2003287050A1
(en)
*
|
2002-10-10 |
2004-05-04 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
CA2501752A1
(en)
*
|
2002-10-10 |
2004-04-22 |
Wyeth |
Compositions, organisms and methodologies employing a novel human kinase
|
WO2004036221A2
(en)
*
|
2002-10-18 |
2004-04-29 |
Wyeth |
Compositions and methods for diagnosing and treating autoimmune disease
|
US7208306B2
(en)
*
|
2002-10-24 |
2007-04-24 |
Wyeth |
Compositions employing a novel human protein phosphatase
|
JP2006515277A
(ja)
|
2002-10-29 |
2006-05-25 |
コーリー ファーマシューティカル グループ, リミテッド |
C型肝炎ウィルス感染の処置および予防に関する方法および製品
|
CA2505416A1
(en)
*
|
2002-11-21 |
2004-06-10 |
Wyeth |
Methods for diagnosing rcc and other solid tumors
|
AU2003290664A1
(en)
*
|
2002-11-27 |
2004-06-23 |
Wei Liu |
Compositions, organisms and methodologies employing a novel human kinase
|
US7803365B2
(en)
*
|
2002-12-02 |
2010-09-28 |
Biovec, Llc |
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases
|
US9388427B2
(en)
|
2002-12-02 |
2016-07-12 |
Biovec, Llc |
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors
|
DE602004015064D1
(de)
*
|
2003-01-06 |
2008-08-28 |
Wyeth Corp |
Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
|
WO2004070062A2
(en)
*
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
WO2004076635A2
(en)
*
|
2003-02-25 |
2004-09-10 |
Biovec B.V. |
Therapeutic applications of thrombomodulin gene via viral and non-viral vectors
|
US20040191818A1
(en)
*
|
2003-02-26 |
2004-09-30 |
O'toole Margot Mary |
Compositions and methods for diagnosing and treating autoimmune diseases
|
CA2517684A1
(en)
*
|
2003-03-04 |
2005-01-13 |
Wyeth |
Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases
|
US20040198640A1
(en)
*
|
2003-04-02 |
2004-10-07 |
Dharmacon, Inc. |
Stabilized polynucleotides for use in RNA interference
|
WO2005001092A2
(en)
*
|
2003-05-20 |
2005-01-06 |
Wyeth |
Compositions and methods for diagnosing and treating cancers
|
WO2005020902A2
(en)
*
|
2003-08-21 |
2005-03-10 |
Cytokine Pharmasciences, Inc. |
Compositions and methods for treating and diagnosing irritable bowel syndrome
|
EP1697511A4
(en)
*
|
2003-12-11 |
2007-11-21 |
Vaxdesign Corp |
IMMUNOTHERAPY COMPOSITIONS, METHODS FOR PREPARING AND USING THE SAME
|
EP2248895B8
(en)
|
2003-12-19 |
2016-09-21 |
Autotelic LLC |
Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent
|
JP2007526253A
(ja)
|
2004-02-19 |
2007-09-13 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫刺激性ウイルスrnaオリゴヌクレオチド
|
EP1568383A3
(en)
|
2004-02-27 |
2005-11-16 |
Antisense Pharma GmbH |
Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
|
KR101147147B1
(ko)
*
|
2004-04-01 |
2012-05-25 |
머크 샤프 앤드 돔 코포레이션 |
Rna 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
|
AU2005247341B2
(en)
|
2004-05-06 |
2008-05-08 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods and compositions for the treatment of uveitis
|
US20060287263A1
(en)
|
2004-07-18 |
2006-12-21 |
Csl Limited |
Methods and compositions for inducing antigen-specific immune responses
|
JP5060293B2
(ja)
|
2004-08-03 |
2012-10-31 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
神経機能におけるtaj
|
KR100721928B1
(ko)
|
2004-11-05 |
2007-05-28 |
주식회사 바이오씨에스 |
CpG 올리고데옥시뉴클레오티드를 함유하는 피부질환의치료 또는 예방용 약학적 조성물
|
US7923206B2
(en)
|
2004-11-22 |
2011-04-12 |
Dharmacon, Inc. |
Method of determining a cellular response to a biological agent
|
US7935811B2
(en)
|
2004-11-22 |
2011-05-03 |
Dharmacon, Inc. |
Apparatus and system having dry gene silencing compositions
|
US7923207B2
(en)
|
2004-11-22 |
2011-04-12 |
Dharmacon, Inc. |
Apparatus and system having dry gene silencing pools
|
WO2006065751A2
(en)
|
2004-12-13 |
2006-06-22 |
Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Cpg oligonucleotide prodrugs, compositions thereof and associated therapeutic methods
|
US7939490B2
(en)
*
|
2004-12-13 |
2011-05-10 |
University Of Maryland, Baltimore |
TWEAK as a therapeutic target for treating central nervous system diseases associated with cerebral edema and cell death
|
FR2881143B1
(fr)
|
2005-01-27 |
2010-12-17 |
Librophyt |
Systeme de production de terpenoides dans les plantes
|
US20100130425A1
(en)
|
2005-09-09 |
2010-05-27 |
Oregon Health & Science University |
Use of toll-like receptor ligands in treating excitotoxic injury, ischemia and/or hypoxia
|
WO2007089601A2
(en)
|
2006-01-27 |
2007-08-09 |
Biogen Idec Ma Inc. |
Nogo receptor antagonists
|
US20080045473A1
(en)
|
2006-02-15 |
2008-02-21 |
Coley Pharmaceutical Gmbh |
Compositions and methods for oligonucleotide formulations
|
US8252755B2
(en)
|
2006-09-22 |
2012-08-28 |
Dharmacon, Inc. |
Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
|
PT2078080E
(pt)
|
2006-09-27 |
2015-09-18 |
Coley Pharm Gmbh |
Análogos dos oligonucleotídeos cpg que contêm análogos t hidrofóbicos com atividade imunoestimulante potenciada
|
AU2007353317B2
(en)
*
|
2006-11-15 |
2012-09-06 |
Eli Lilly And Company |
Methods and compositions for treating influenza
|
DK2170353T3
(en)
|
2007-05-18 |
2015-07-27 |
Adiutide Pharmaceuticals Gmbh |
The phosphate-modified oligonucleotide analogs with immunostimulatory activity
|
RU2010112771A
(ru)
|
2007-10-09 |
2011-11-20 |
Коули Фармасьютикал ГмбХ (DE) |
Иммуностимулирующие аналоги олигонуклеотидов, содержащие модифицированные сахарные группировки
|
JP5753382B2
(ja)
|
2007-11-06 |
2015-07-22 |
アディウティーダ ファーマシューティカルズ ゲーエムベーハー |
修飾されたオリゴリン酸基を含有する免疫賦活オリゴリボヌクレオチドアナログ
|
US7845686B2
(en)
*
|
2007-12-17 |
2010-12-07 |
S & B Technical Products, Inc. |
Restrained pipe joining system for plastic pipe
|
US8188060B2
(en)
|
2008-02-11 |
2012-05-29 |
Dharmacon, Inc. |
Duplex oligonucleotides with enhanced functionality in gene regulation
|
WO2009143292A2
(en)
|
2008-05-21 |
2009-11-26 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Method of treating pneumoconiosis with oligodeoxynucleotides
|
ES2622562T3
(es)
|
2008-12-09 |
2017-07-06 |
Pfizer Vaccines Llc |
Vacuna de péptido CH3 de IgE
|
US8552165B2
(en)
|
2008-12-09 |
2013-10-08 |
Heather Davis |
Immunostimulatory oligonucleotides
|
SI2759306T1
(sl)
|
2008-12-09 |
2016-05-31 |
Coley Pharmaceutical Group, Inc. |
Imunostimulacijski oligonukleotidi
|
US20120052088A1
(en)
|
2009-04-30 |
2012-03-01 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
CN102712924A
(zh)
|
2009-07-30 |
2012-10-03 |
安提森斯制药有限公司 |
化疗药剂和TGF-β系统抑制剂的组合
|
JP2013500326A
(ja)
|
2009-07-30 |
2013-01-07 |
ファイザー バクシーンズ エルエルシー |
抗原性タウペプチドおよびその使用
|
WO2011027257A2
(en)
|
2009-09-03 |
2011-03-10 |
Pfizer Vaccines Llc |
Pcsk9 vaccine
|
US8685416B2
(en)
|
2010-03-02 |
2014-04-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compositions and methods for the treatment of cancer
|
DK2575878T3
(en)
|
2010-05-28 |
2018-08-13 |
Zoetis Belgium S A |
VACCINES INCLUDING CHOLESTEROL AND CPG AS THE ONLY ADJUVENT CARRIER MOLECULES
|
WO2011154878A1
(en)
|
2010-06-07 |
2011-12-15 |
Pfizer Vaccines Llc |
Ige ch3 peptide vaccine
|
US9920317B2
(en)
|
2010-11-12 |
2018-03-20 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
AU2011325956B2
(en)
|
2010-11-12 |
2016-07-14 |
The General Hospital Corporation |
Polycomb-associated non-coding RNAs
|
WO2012131504A1
(en)
|
2011-03-02 |
2012-10-04 |
Pfizer Inc. |
Pcsk9 vaccine
|
KR20140050027A
(ko)
|
2011-07-01 |
2014-04-28 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
예정된 형상을 갖는 나노입자의 형성 방법
|
EP2756080B1
(en)
|
2011-09-14 |
2019-02-20 |
Translate Bio MA, Inc. |
Multimeric oligonucleotide compounds
|
WO2013148186A1
(en)
|
2012-03-26 |
2013-10-03 |
President And Fellows Of Harvard College |
Lipid-coated nucleic acid nanostructures of defined shape
|
AU2013252785B2
(en)
|
2012-04-27 |
2017-05-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of CpG oligonucleotides co-formulated with an antibiotic to accelarate wound healing
|
KR20200075023A
(ko)
|
2012-05-04 |
2020-06-25 |
화이자 인코포레이티드 |
전립선 관련된 항원 및 백신 기재 면역치료 요법
|
EA201492120A1
(ru)
|
2012-05-16 |
2015-10-30 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии atp2a2
|
AU2013262649A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating smn gene family expression
|
US10837014B2
(en)
|
2012-05-16 |
2020-11-17 |
Translate Bio Ma, Inc. |
Compositions and methods for modulating SMN gene family expression
|
WO2013173645A1
(en)
|
2012-05-16 |
2013-11-21 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating utrn expression
|
AU2013262700A1
(en)
|
2012-05-16 |
2015-01-22 |
Rana Therapeutics, Inc. |
Compositions and methods for modulating hemoglobin gene family expression
|
EA201492116A1
(ru)
|
2012-05-16 |
2015-05-29 |
Рана Терапьютикс, Инк. |
Композиции и способы для модулирования экспрессии mecp2
|
AU2013287630B2
(en)
|
2012-07-13 |
2017-05-25 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
JP2015529469A
(ja)
|
2012-09-14 |
2015-10-08 |
ラナ セラピューティクス インコーポレイテッド |
多量体オリゴヌクレオチド化合物
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
JP2016531570A
(ja)
|
2013-08-16 |
2016-10-13 |
ラナ セラピューティクス インコーポレイテッド |
ユークロマチン領域を標的とするオリゴヌクレオチド
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
EP3095461A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
JPWO2015108046A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
EP3134550B1
(en)
|
2014-04-23 |
2019-09-04 |
Children's Medical Center Corporation |
High-throughput structure determination using nucleic acid calipers
|
WO2016070060A1
(en)
|
2014-10-30 |
2016-05-06 |
The General Hospital Corporation |
Methods for modulating atrx-dependent gene repression
|
LT3240801T
(lt)
|
2014-12-31 |
2021-02-25 |
Checkmate Pharmaceuticals, Inc. |
Kombinuota navikų imunoterapija
|
EP3256591A4
(en)
|
2015-02-13 |
2018-08-08 |
Translate Bio Ma, Inc. |
Hybrid oligonucleotides and uses thereof
|
US10900036B2
(en)
|
2015-03-17 |
2021-01-26 |
The General Hospital Corporation |
RNA interactome of polycomb repressive complex 1 (PRC1)
|
WO2016183370A1
(en)
|
2015-05-13 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Synthetic immunosuppressive oligodeoxynucleotides reduce ischemic tissue damage
|
WO2016183371A1
(en)
|
2015-05-13 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods for the treatment or prevention of ischemic tissue damage
|
US20190298824A1
(en)
|
2016-05-04 |
2019-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Serv |
Albumin-binding immunomodulatory compositions and methods of use thereof
|
AU2018378827B2
(en)
|
2017-12-07 |
2023-04-13 |
Massachusetts Institute Of Technology |
Single cell analyses
|
WO2021154745A1
(en)
|
2020-01-27 |
2021-08-05 |
Oregon State University |
Gonorrhea subunit vaccine
|
WO2024127215A2
(en)
|
2022-12-13 |
2024-06-20 |
Pfizer Inc. |
Immunogenic compositions and methods for eliciting an immune response against clostridioides (clostridium) difficile
|